FDA Warns Chinese Devicemaker for Quality Failures By Sam | May 12, 2020 Failure to control nonconforming products landed Dongguan Microview Medical a warning letter following an FDA inspection of its facility in Guangdong, China. Source: The GMP Letter Posted in The GMP Letter